Mar 15, 2024, 15:38
Elisa Agostinetto: Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence
Elisa Agostinetto, Clinical Research Fellow at Jules Bordet Institute in Brussels, shared a post on X:
“Our last meta-analysis led by Guilherme Nader Marta shows that ctDNA detection in early breast cancer is associated with higher risk of recurrence, ctDNA detection had very high specificity for anticipating relapse.”
View the article.
Source: Elisa Agostinetto/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 15:06
Jan 15, 2025, 14:33
Jan 15, 2025, 14:27
Jan 15, 2025, 14:23
Jan 15, 2025, 14:22
Jan 15, 2025, 14:19
Jan 15, 2025, 14:17